Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2014-07-07 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOULOGNE BILLANCOURT (92100), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS LA PHARMACIE DE ROLAND GARROS : revenue, balance sheet and financial ratios
SELAS LA PHARMACIE DE ROLAND GARROS is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOULOGNE BILLANCOURT (92100),
this company of category PME
shows in 2022 a net income positive of 132 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS LA PHARMACIE DE ROLAND GARROS (SIREN 803176387)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
132 398 €
222 069 €
49 753 €
28 179 €
37 756 €
85 431 €
79 836 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, SELAS LA PHARMACIE DE ROLAND GARROS generates positive net income of 132 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 80 k€ -> 132 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
132 398 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
42.874%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
52.052%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS LA PHARMACIE DE ROLAND GARROS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
456.791
231.953
177.547
170.019
128.255
65.584
42.874
Financial autonomy
14.297
24.47
28.872
27.808
31.82
42.91
52.052
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
42.872022
2020
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Good-22 pts over 3 years
In 2022, the debt ratio of SELAS LA PHARMACIE DE ROL... (42.87) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
52.05%2022
2020
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Good+20 pts over 3 years
In 2022, the financial autonomy of SELAS LA PHARMACIE DE ROL... (52.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 199.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
199.101
Liquidity indicators evolution SELAS LA PHARMACIE DE ROLAND GARROS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
215.049
242.216
229.831
181.594
172.595
179.907
199.101
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
199.12022
2020
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Average
In 2022, the liquidity ratio of SELAS LA PHARMACIE DE ROL... (199.10) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELAS LA PHARMACIE DE ROLAND GARROS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of SELAS LA PHARMACIE DE ROLAND GARROS is estimated at
1 557 862 €
(range 1 047 192€ - 2 336 504€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
1047k€1557k€2336k€
1 557 862 €Range: 1 047 192€ - 2 336 504€
NAF 5 année 2022
Valuation method used
Net Income Multiple
132 398 €
×
11.8x
=1 557 862 €
Range: 1 047 193€ - 2 336 504€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS LA PHARMACIE DE ROLAND GARROS with other companies in the same sector:
Frequently asked questions about SELAS LA PHARMACIE DE ROLAND GARROS
What is the revenue of SELAS LA PHARMACIE DE ROLAND GARROS ?
The revenue of SELAS LA PHARMACIE DE ROLAND GARROS is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS LA PHARMACIE DE ROLAND GARROS profitable?
Yes, SELAS LA PHARMACIE DE ROLAND GARROS generated a net profit of 132 k€ in 2022.
Where is the headquarters of SELAS LA PHARMACIE DE ROLAND GARROS ?
The headquarters of SELAS LA PHARMACIE DE ROLAND GARROS is located in BOULOGNE BILLANCOURT (92100), in the department Hauts-de-Seine.
Where to find the tax return of SELAS LA PHARMACIE DE ROLAND GARROS ?
The tax return of SELAS LA PHARMACIE DE ROLAND GARROS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS LA PHARMACIE DE ROLAND GARROS operate?
SELAS LA PHARMACIE DE ROLAND GARROS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart